Expert Perspectives: The Role of Immunotherapy in Advancing the Treatment of HCC and BTC
Considering a Comprehensive Approach for Bronchiectasis Management
Addressing the Unmet Needs of Myotonic Dystrophy Type 1 (DM1)
A ACCME Accredited provider.
The France Foundation ©
Chandler Building, 84 Lyme Street, Old Lyme, CT USA